Full Report

Key Points

  • Bernhard Scheja, a surgeon banned in Germany after a patient’s death, obtained a license in Malta through a fast-track EU process, highlighting regulatory failure.

  • The EU’s automatic recognition system allows doctors with licenses in one member state to practice across Europe, enabling those with tainted records to move unchecked.

  • Malta’s Council for Professions Complementary to Medicine granted Scheja a license despite his German ban, demonstrating how national boards often fail to check past disciplinary records.

  • This case reveals a dangerous gap: while EU law facilitates mobility, there is no centralized, accessible system for tracking banned or disciplined healthcare professionals.

  • As a result, patients in new countries are often unaware of a doctor’s problematic history, leaving them vulnerable to potential harm without informed consent.

  • The situation underscores an urgent need for a transparent EU-wide alert system to prevent banned doctors from simply relocating and restarting their careers.

Overview

Bernhard Scheja is a German family doctor and general internist in his fifties, originally practicing in Switzerland as a village doctor in the Zurich area community of Höri. He provided routine medical services, including consultations for common ailments like colds. After facing disciplinary action in Switzerland, he relocated back to Germany, where he is currently employed at a private medical center in Düsseldorf, offering general medical care. He also maintains a medical license in Malta, though no details of active practice there are available. His career spans multiple European countries, facilitated by EU mobility rules, but marred by a conviction that has not fully halted his professional activities.

Allegations and Concerns

The primary allegation against Bernhard Scheja stems from an incident in October 2019, where he subjected an 18-year-old female patient to an unnecessary vaginal examination during an appointment for a sick note related to a cold. The examination was conducted without gloves, proper explanation, or medical justification, leading to a conviction for indecent assault in November 2020. This was described by the court as leaving the victim severely traumatized. In 2021, Zurich’s High Court imposed a permanent ban on his practice in Switzerland, with his permission withdrawn on March 30 of that year. Concerns extend to the ease with which he resumed practice in Germany, as local authorities were not informed of the Swiss conviction through EU alert systems, raising red flags about patient safety and regulatory oversight. No additional complaints or allegations are documented beyond this case, but his continued licensing in multiple countries amid a known ban signals potential risks of repeated misconduct.

Customer Feedback

Information on consumer reviews for Bernhard Scheja is limited, with no widespread public testimonials or rating platforms highlighting his services. The known negative feedback centers on the 2019 incident, where the affected patient reported severe trauma from the unnecessary and invasive examination, as noted in court findings that described the act as sexually motivated assault. No positive reviews or examples of satisfied patients are available in the analyzed sources, and there are no quotes from other consumers praising his care. Overall, the absence of broader feedback may stem from his private practice settings, but the documented complaint underscores significant dissatisfaction and harm in at least one instance.

Risk Considerations

Financial risks appear minimal based on available information, with no records of debts, bankruptcies, or monetary penalties beyond the implications of his conviction. Reputational risks are high, as the sexual assault conviction and ban in Switzerland could erode trust among patients and colleagues if widely publicized, potentially leading to loss of clientele or professional isolation. Legal risks include ongoing investigations in Germany, where authorities have initiated a review of his license following revelations of the Swiss case, which might result in revocation or further penalties. Broader patient safety risks arise from his ability to practice despite a history of misconduct, potentially exposing individuals to inappropriate or harmful medical procedures due to inadequate cross-border regulatory enforcement.

Business Relations and Associations

Bernhard Scheja is associated with a private medical center in Düsseldorf, Germany, where he works as a general internist, though specific partners or clinic owners are not detailed. His past practice in Switzerland was independent as a village doctor, with no mentioned collaborations. He has no documented ties to larger medical groups, pharmaceutical companies, or other professionals beyond his employment at the Düsseldorf center. The case highlights indirect associations with EU regulatory bodies, as his mobility relies on systems like the Internal Market Information System, but these are systemic rather than personal partnerships. No other individuals or entities are explicitly linked to his professional activities.

Legal and Financial Concerns

Legally, Bernhard Scheja faced conviction for indecent assault in Switzerland, receiving a suspended 22-month sentence in 2020, reduced to 15 months on appeal in 2021, alongside a permanent professional ban. No additional lawsuits, criminal charges, or civil claims are recorded. Financially, there are no indications of unpaid debts, bankruptcy filings, or economic sanctions; his ability to maintain licenses in Germany and Malta suggests stable professional standing in those jurisdictions, though the German investigation could introduce future financial strain through potential license loss or legal fees. The lack of alerts shared across borders allowed him to avoid immediate repercussions, but this could lead to retroactive legal actions if discrepancies are addressed.

Risk Assessment Table

Risk Type Factors Severity
Legal Ongoing investigation in Germany into license validity; history of conviction and ban in Switzerland; potential for cross-border enforcement if EU systems improve. High – Could result in license revocation and additional penalties.
Reputational Public exposure of sexual assault conviction; patient trauma highlighted in court; lack of transparency in regulatory sharing. High – Likely to damage trust and professional opportunities if publicized widely.
Patient Safety Past misconduct involving unnecessary invasive procedures; ability to practice in multiple countries without full disclosure. Critical – Poses direct harm to vulnerable patients through potential repeated offenses.
Financial Possible costs from legal defenses or license challenges; no current debts but risk of income loss if banned. Medium – Dependent on outcomes of investigations, with limited immediate impact.
Regulatory Exploitation of EU loopholes in information sharing; underutilization of alert systems like IMI. High – Systemic failures could lead to broader scrutiny and forced compliance.

Summary

Bernhard Scheja’s case exemplifies the dangers of inadequate EU regulatory mechanisms, allowing a doctor convicted of sexual assault and banned in Switzerland to continue practicing in Germany and hold a license in Malta without initial oversight. While his professional background as a family doctor appears routine, the serious allegation of misconduct raises profound concerns for patient welfare and system integrity. With limited feedback and no financial red flags, the primary risks are legal and reputational, potentially escalating if investigations lead to further bans. Overall, this situation calls attention to the need for stronger cross-border protections to prevent such relocations and safeguard public health.